BRAF and neoplasm: The most abundant mutation is BRAFV600E, which represents approximately 90% of all BRAFV600 mutations (which represent about 90% of all BRAF mutations) in melanoma and fosters tumor proliferation, survival, invasiveness, and drug resistance[3].